دورية أكاديمية
أعرض في EDS

Quality appraisal of clinical guidelines for recurrent urinary tract infections using AGREE II: a systematic review.

التفاصيل البيبلوغرافية
العنوان: Quality appraisal of clinical guidelines for recurrent urinary tract infections using AGREE II: a systematic review.
المؤلفون: Pat JJ; Department of General Practice and Elderly Care Medicine, University Medical Centre Groningen, Groningen, The Netherlands. j.j.pat@umcg.nl.; Department of Urology, Isala clinics, Dokter van Heesweg 2, 8025, AB, Zwolle, The Netherlands. j.j.pat@umcg.nl., Witte LPW; Department of Urology, Isala clinics, Dokter van Heesweg 2, 8025, AB, Zwolle, The Netherlands., Steffens MG; Department of Urology, Isala clinics, Dokter van Heesweg 2, 8025, AB, Zwolle, The Netherlands., Vernooij RWM; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Marcelissen TAT; Department of Urology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Fuentes P; Faculty of Medicine and Dentistry, Universidad de Antofagasta, Antofagasta, Chile.; Servicio de Salud Antofagasta, Antofagasta, Chile.; Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau), CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain., Garcia-Perdomo HA; Division of Urology Department of Surgery. School of Medicine, Universidad del Valle, Cali, Colombia., Pardo-Hernandez H; Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau), CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain., Blanker MH; Department of General Practice and Elderly Care Medicine, University Medical Centre Groningen, Groningen, The Netherlands.
المصدر: International urogynecology journal [Int Urogynecol J] 2022 May; Vol. 33 (5), pp. 1059-1070. Date of Electronic Publication: 2022 Feb 10.
نوع المنشور: Journal Article; Review; Systematic Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: England NLM ID: 101567041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-3023 (Electronic) Linking ISSN: 09373462 NLM ISO Abbreviation: Int Urogynecol J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Springer
مواضيع طبية MeSH: Urinary Tract Infections*/diagnosis , Urinary Tract Infections*/therapy, Humans
مستخلص: Introduction and Hypothesis: Recommendations for preventing and diagnosing recurrent urinary tract infection (UTI) tend to vary between clinical practice guidelines (CPGs) because of low-quality scientific evidence, potentially leading to practice variation and suboptimal care. We assessed the quality of existing CPGs for recurrent UTI.
Methods: A systematic search was performed from January 2000 to June 2021 in PubMed and EMBASE for CPGs on recurrent UTI prevention or hospital diagnostics in Dutch, English, and Spanish. Each CPG was assessed by four appraisers in a multidisciplinary review team, using the Appraisal of Guidelines, Research, and Evaluation II (AGREE II) instrument.
Results: We identified and assessed eight CPGs published between 2013 and 2021. The scope and purpose (mean and standard deviation: 67.3 ± 21.8) and clarity of presentation (74.8 ± 17.6) domains scored highly. However, issues with methods, patient participation, conflict of interests, and facilitators and barriers were common and resulted in lower scores for the rigour of development (56.9 ± 25.9), applicability (19.6 ± 23.4), stakeholder involvement (50.4 ± 24.6), and editorial independence (62.1 ± 23.1) domains. Overall, two CPGs were recommended, three were recommended with modifications, and three were not recommended.
Conclusions: Significant room for improvement exists in the quality of CPGs for recurrent UTI, with most displaying serious limitations in the stakeholder involvement, rigour of development, and applicability domains. These aspects must be improved to decrease diagnostic and therapeutic uncertainty. Developers could benefit from using checklists and following guidelines when developing de novo CPGs.
(© 2022. The Author(s).)
References: Arthritis Res Ther. 2007;9(6):R126. (PMID: 18062805)
Eur Urol. 2020 Nov;78(5):645-646. (PMID: 32616407)
Urology. 2019 Jun;128:47-54. (PMID: 30796990)
Int J Antimicrob Agents. 2002 Jun;19(6):451-6. (PMID: 12135831)
Int Urogynecol J. 2022 Aug;33(8):2283-2289. (PMID: 34125244)
Urol Int. 2018;101(4):373-381. (PMID: 30016804)
Actas Urol Esp. 2015 Jul-Aug;39(6):339-48. (PMID: 25454264)
JAMA. 1999 Oct 20;282(15):1458-65. (PMID: 10535437)
Int J Antimicrob Agents. 2009 Feb;33(2):111-9. (PMID: 18963856)
Urol Int. 2018;100(3):271-278. (PMID: 29539622)
Actas Urol Esp. 2016 May;40(4):203-8. (PMID: 26601727)
PLoS One. 2014 May 19;9(5):e95369. (PMID: 24840205)
Implement Sci. 2014 Jan 02;9:3. (PMID: 24383701)
Expert Rev Pharmacoecon Outcomes Res. 2018 Feb;18(1):107-117. (PMID: 28737469)
Spine J. 2015 Apr 1;15(4):777-81. (PMID: 25614152)
Am J Epidemiol. 2000 Jun 15;151(12):1194-205. (PMID: 10905532)
Z Evid Fortbild Qual Gesundhwes. 2017 Nov;127-128:3-10. (PMID: 29128430)
J Urol. 2019 Aug;202(2):282-289. (PMID: 31042112)
PLoS One. 2014 Nov 17;9(11):e111796. (PMID: 25402504)
Qual Saf Health Care. 2010 Dec;19(6):e58. (PMID: 21127089)
Urol Int. 2018;100(3):263-270. (PMID: 29342469)
J Urol. 2013 Dec;190(6):1981-9. (PMID: 23867306)
J Eval Clin Pract. 2007 Aug;13(4):657-64. (PMID: 17683311)
فهرسة مساهمة: Keywords: AGREE; Guideline; Recurrent urinary tract infections; Review
تواريخ الأحداث: Date Created: 20220210 Date Completed: 20220523 Latest Revision: 20240827
رمز التحديث: 20240827
مُعرف محوري في PubMed: PMC9119892
DOI: 10.1007/s00192-022-05089-6
PMID: 35142870
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-3023
DOI:10.1007/s00192-022-05089-6